Please assess the completion status of the following clinical trial:

Trial Title: Effect of Probiotics on Sputum Inflammation and Pulmonary Infections in Patients With Cystic Fibrosis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* cystic fibrosis mild to moderate~* at least 3 pulmonary exacerbations requiring antibiotics per year~* Pseudomonas aeruginosa in the sputum~* able to produce sputum~Exclusion Criteria:~* severe pulmonary disease~* less than 3 pulmonary exacerbations per year~* unable to produce sputum

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 40 Years
- Healthy Volunteers: f

Study Arms:
- Probiotics, Treatment, Food Additive (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).